<DOC>
	<DOCNO>NCT02768974</DOCNO>
	<brief_summary>This proof concept , randomize , open label , 2-arm study OPRX-106 subject active mild moderate ulcerative colitis . Eligible subject enrol randomize receive 2 mg 8 mg OPRX-106 administer orally , daily 8 week .</brief_summary>
	<brief_title>Open Label Study Assess Safety , PK Explore Efficacy OPRX-106 Patients With Active Mild Moderate Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Main 1 . Have diagnosis ulcerative colitis minimum 3 month 2 . Have active mild moderate ulcerative colitis , define full Mayo score screen 3 . Have adequate cardiac , renal hepatic function determine investigator demonstrate screen clinical laboratory evaluation , physical examination result 4 . High level calprotectin ( &gt; 100 mg/kg stool ) Main 1 . Have history colonic rectal surgery hemorrhoidal surgery appendectomy 2 . .Positive active/ latent mycobacterium tuberculosis ( TB ) infection 3 . .Have history infection require administration IV antibiotic , antiviral antifungal medication oral antiinfective agent 4 . Severe ulcerative colitis 5 . Ulcerative proctitis , define disease limit less 15 cm anal verge 6 . Use &gt; 4.8 g 5ASA equivalent 7 . Use corticosteroid 5ASA enema , foam , suppository 8 . Use antiinflammatory medication natural remedy 9 . Use oral parenteral antibiotic 10 . Use chronic nonsteroidal antiinflammatory ( NSAID ) therapy 11 . Use immune suppressive agent include antiTNF agent , Azathioprine , 6MP , Methotrexate 12 . Use steroids 13 . Have diagnosis : Crohn 's disease ; Indeterminate colitis ; Microscopic colitis ; Ischemic infectious colitis ; Clostridium difficile colitis , Parasitic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>